GL1X · GenesisL1 explorer

Research workbench

Crystal structure of orotate phosphoribosyltransferase from streptococcus pyogenes

Analyse Crystal structure of orotate phosphoribosyltransferase from streptococcus… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2AEE
Type
protein
Length
409 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Orotate phosphoribosyltransferase
EC
2.4.2.10
UniProt
Q9A076
Ligands
SO4, CL
Pockets
2 · best druggability 0.47

Structure

x-ray diffraction · 2 distinct chains · 45% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AOrotate phosphoribosyltransferase (EC 2.4.2.10)protein20646% helix, 21% strandQ9A076
BOrotate phosphoribosyltransferase (EC 2.4.2.10)protein20345% helix, 23% strandQ9A076

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • CL · Chloride ion · ion · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12110.470.7432SO4, GOL
21700.440.7532SO4, GOL

Interfaces

1 interface between chains.

  • A–B · 1352 Ų buried · 29 hydrogen bonds · protein-protein

Compared structures

  • 2AEE · Crystal structure of Orotate phosphoribosyltransferase from Streptococcus pyogenes · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9A076 · AlphaFold monomer V2.0 prediction for orotate phosphoribosyltransferase (Q9A076) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.